InvestorsHub Logo
Followers 20
Posts 1059
Boards Moderated 0
Alias Born 04/01/2013

Re: Iamastockgenius post# 9383

Thursday, 06/27/2013 10:04:02 AM

Thursday, June 27, 2013 10:04:02 AM

Post# of 426735
JZ would have been killed by people if they did that.

They repeatedly went with 3 options, NCE seemed to be a hold up, if they then went GIA and diluted that would have been worse than what happened IMO.

I think they know Lovaza is off label for a large amount of sales, I think they know the Marine penetration can only be so much with getting people to switch to Lovaza with Tier 2 for Lovaza and a drug people have been taking that works enough for them to stay on it.

Hiring a large sales force for Marine I think would not have been a good use of dilution.

According to JZ with the force they have they will have seen 70% of cardiologists targeted 4-5 times by end of Q2 so it seems they have the Marine market in cardiologists covered properly so hard to say the sales force is too small for Marine.

The other problem was most large investors expected a drop to 8 on GIA so when going to get new stock sold to investors they likely would have gotten less than 8 and, again, JZ would have been killed over that. If they were diluting that meant GIA to the people buying the new stock which meant selling stock at 8 when price was 12-15, how would that have gone over?

Their approach is a long term one with Anchor the focus of the reward, if they mess up on Anchor launch criticism will be justified, but since the main "product" they have to sell is Anchor and the value of the business will be determined by Anchor(and later REDUCE IT) I need to see Anchor play out before I can criticize management despite the stock price drop.

I can wait the 6 months. It's just a waiting game on Anchor right now.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News